Literature DB >> 17028601

Viruses, microRNAs and cancer.

S Pfeffer1, O Voinnet.   

Abstract

Viruses represent one of the main factors that cause normal cells to proliferate and to become malignant: up to 15% of all human cancers are associated with single or multiple virus infections, and several viruses have been recognized as causal agents of specific types of cancer. Viruses have evolved many strategies to prevent infected cells from becoming apoptotic and to evade the innate and adaptive immune responses of their hosts. The recent discovery that Epstein-Barr virus and other herpesviruses produce their own sets of micro (mi)RNAs brings an additional layer of complexity in this ongoing host-virus arms race and changes our initial views of the antiviral roles of RNA silencing in plants and insects. It seems that, rather than being inhibited by this process, many mammalian viruses can usurp or divert the host RNA silencing machinery to their advantage. Viral-encoded miRNAs can act both in cis, to ensure accurate expression of viral genomes, and in trans, to modify the expression of host transcripts. Here, we review the current knowledge on viral miRNAs and discuss how mammalian viruses can also perturb host miRNA expression. Those recent findings provide new insights into the role of viruses and miRNAs in cancer development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17028601     DOI: 10.1038/sj.onc.1209915

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  37 in total

1.  Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence.

Authors:  Fang Lu; Andreas Weidmer; Chang-Gong Liu; Stefano Volinia; Carlo M Croce; Paul M Lieberman
Journal:  J Virol       Date:  2008-08-27       Impact factor: 5.103

Review 2.  Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

Authors:  Georgia Sotiropoulou; Georgios Pampalakis; Evi Lianidou; Zissimos Mourelatos
Journal:  RNA       Date:  2009-06-26       Impact factor: 4.942

Review 3.  Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges.

Authors:  Paul G Rubinstein; David M Aboulafia; Andrew Zloza
Journal:  AIDS       Date:  2014-02-20       Impact factor: 4.177

4.  Pan-viral-microRNA screening identifies interferon inhibition as a common function of diverse viruses.

Authors:  Jennifer E Cox; Lydia V McClure; Andrei Goga; Christopher S Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-01-26       Impact factor: 11.205

5.  Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.

Authors:  Eri Seto; Andreas Moosmann; Sebastian Grömminger; Nicole Walz; Adam Grundhoff; Wolfgang Hammerschmidt
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

6.  Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints.

Authors:  Alessandro Laganà; Stefano Forte; Francesco Russo; Rosalba Giugno; Alfredo Pulvirenti; Alfredo Ferro
Journal:  J RNAi Gene Silencing       Date:  2010-05-24

7.  Murine Polyomavirus encodes a microRNA that cleaves early RNA transcripts but is not essential for experimental infection.

Authors:  Christopher S Sullivan; Chang K Sung; Christopher D Pack; Adam Grundhoff; Aron E Lukacher; Thomas L Benjamin; Don Ganem
Journal:  Virology       Date:  2009-03-09       Impact factor: 3.616

8.  Discrete clusters of virus-encoded micrornas are associated with complementary strands of the genome and the 7.2-kilobase stable intron in murine cytomegalovirus.

Authors:  Amy H Buck; Javier Santoyo-Lopez; Kevin A Robertson; Diwakar S Kumar; Martin Reczko; Peter Ghazal
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

9.  Evolutionarily conserved function of a viral microRNA.

Authors:  G J Seo; L H L Fink; B O'Hara; W J Atwood; C S Sullivan
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

10.  Expression and processing of a small nucleolar RNA from the Epstein-Barr virus genome.

Authors:  Roland Hutzinger; Regina Feederle; Jan Mrazek; Natalia Schiefermeier; Piotr J Balwierz; Mihaela Zavolan; Norbert Polacek; Henri-Jacques Delecluse; Alexander Hüttenhofer
Journal:  PLoS Pathog       Date:  2009-08-14       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.